Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Express stock logo
AXP
American Express
$231.46
-1.1%
$223.94
$140.91
$240.55
$166.49B1.233.22 million shs4.14 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$151.16
+4.5%
$154.65
$143.13
$175.97
$348.43B0.558.28 million shs14.47 million shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Express stock logo
AXP
American Express
-1.14%-3.25%+1.74%+13.90%+51.03%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+4.53%+1.77%-4.20%-4.55%-8.40%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Express stock logo
AXP
American Express
4.6013 of 5 stars
2.14.02.53.03.22.52.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.928 of 5 stars
3.23.04.23.93.72.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Express stock logo
AXP
American Express
2.26
Hold$210.71-8.96% Downside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8616.34% Upside

Current Analyst Ratings

Latest AXP and JNJ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2024
American Express stock logo
AXP
American Express
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$253.00 ➝ $263.00
5/1/2024
American Express stock logo
AXP
American Express
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$190.00 ➝ $205.00
4/26/2024
American Express stock logo
AXP
American Express
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/24/2024
American Express stock logo
AXP
American Express
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$243.00 ➝ $255.00
4/24/2024
American Express stock logo
AXP
American Express
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$250.00 ➝ $265.00
4/22/2024
American Express stock logo
AXP
American Express
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$221.00 ➝ $225.00
4/22/2024
American Express stock logo
AXP
American Express
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$240.00 ➝ $260.00
4/22/2024
American Express stock logo
AXP
American Express
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$250.00 ➝ $253.00
4/22/2024
American Express stock logo
AXP
American Express
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$167.00 ➝ $175.00
4/22/2024
American Express stock logo
AXP
American Express
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$222.00 ➝ $226.00
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
(Data available from 5/2/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Express stock logo
AXP
American Express
$60.52B2.75$13.43 per share17.24$39.99 per share5.79
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.28$14.29 per share10.58$28.57 per share5.29

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Express stock logo
AXP
American Express
$8.37B$12.1419.0715.621.3614.50%32.46%3.51%7/19/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.4213.832.3845.26%36.43%15.01%7/18/2024 (Estimated)

Latest AXP and JNJ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/19/2024Q1 24
American Express stock logo
AXP
American Express
$2.97$3.33+$0.36$3.33$15.79 billion$15.80 billion      
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Express stock logo
AXP
American Express
$2.801.21%+10.49%23.06%3 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.15%+5.70%29.68%63 Years

Latest AXP and JNJ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
3/6/2024
American Express stock logo
AXP
American Express
quarterly$0.100.18%4/4/20244/5/20245/10/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Express stock logo
AXP
American Express
1.70
1.62
1.62
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.38
1.16
0.91

Ownership

Institutional Ownership

CompanyInstitutional Ownership
American Express stock logo
AXP
American Express
84.33%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
American Express stock logo
AXP
American Express
0.11%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
American Express stock logo
AXP
American Express
74,600719.30 million718.51 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.41 billionOptionable

AXP and JNJ Headlines

SourceHeadline
Intact Investment Management Inc. Sells 19,700 Shares of Johnson & Johnson (NYSE:JNJ)Intact Investment Management Inc. Sells 19,700 Shares of Johnson & Johnson (NYSE:JNJ)
marketbeat.com - May 2 at 5:55 AM
Raymond James Financial Services Advisors Inc. Acquires 88,849 Shares of Johnson & Johnson (NYSE:JNJ)Raymond James Financial Services Advisors Inc. Acquires 88,849 Shares of Johnson & Johnson (NYSE:JNJ)
marketbeat.com - May 1 at 11:06 PM
Johnson & Johnson moves forward with $6.475 billion settlement of talc cancer lawsuitsJohnson & Johnson moves forward with $6.475 billion settlement of talc cancer lawsuits
finance.yahoo.com - May 1 at 6:01 PM
US STOCKS-S&P 500, Nasdaq end lower after Fed rate decision, Powell press conferenceUS STOCKS-S&P 500, Nasdaq end lower after Fed rate decision, Powell press conference
finance.yahoo.com - May 1 at 6:01 PM
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices PlungeStock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
investorplace.com - May 1 at 3:57 PM
Johnson & Johnson (NYSE:JNJ) Shares Up 4.4%Johnson & Johnson (NYSE:JNJ) Shares Up 4.4%
marketbeat.com - May 1 at 1:59 PM
Janssen adopts J&J name as part of global rebranding effortJanssen adopts J&J name as part of global rebranding effort
pharmaceutical-technology.com - May 1 at 1:00 PM
JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer LawsuitsJNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits
investorplace.com - May 1 at 11:26 AM
Johnson & Johnson proposes to pay $6.5B to settle talc ovarian cancer lawsuits in USJohnson & Johnson proposes to pay $6.5B to settle talc ovarian cancer lawsuits in US
foxbusiness.com - May 1 at 10:15 AM
Johnson & Johnson Proposes Nearly $6.5B Package to Settle Talc Ovarian Cancer SuitsJohnson & Johnson Proposes Nearly $6.5B Package to Settle Talc Ovarian Cancer Suits
investopedia.com - May 1 at 9:55 AM
Johnson & Johnson proposes $6.475 billion settlement in talc lawsuitsJohnson & Johnson proposes $6.475 billion settlement in talc lawsuits
invezz.com - May 1 at 8:45 AM
Beasley Allen Law Firm: Attorneys for Women Harmed by Johnson & Johnsons Talcum Powder Resist Companys Attempt to Stuff Ballot Box in Unprecedented Third Attempted BankruptcyBeasley Allen Law Firm: Attorneys for Women Harmed by Johnson & Johnson's Talcum Powder Resist Company's Attempt to Stuff Ballot Box in Unprecedented Third Attempted Bankruptcy
businesswire.com - May 1 at 8:26 AM
J&J Seeks Backing for $11 Billion Baby Powder Cancer DealJ&J Seeks Backing for $11 Billion Baby Powder Cancer Deal
finance.yahoo.com - May 1 at 8:00 AM
J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuitsJ&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits
finance.yahoo.com - May 1 at 8:00 AM
J&J subsidiary proposes paying about $6.48B over 25 years to settle talc lawsuitsJ&J subsidiary proposes paying about $6.48B over 25 years to settle talc lawsuits
marketbeat.com - May 1 at 7:15 AM
J&J advances $6.475 billion settlement of talc cancer lawsuitsJ&J advances $6.475 billion settlement of talc cancer lawsuits
reuters.com - May 1 at 6:34 AM
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
cnbc.com - May 1 at 6:31 AM
Johnson & Johnson (NYSE:JNJ) Shares Acquired by Sapient Capital LLCJohnson & Johnson (NYSE:JNJ) Shares Acquired by Sapient Capital LLC
marketbeat.com - April 30 at 11:53 PM
Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & JohnsonJudge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson
msn.com - April 30 at 4:23 PM
Spotlight on Johnson & Johnson: Analyzing the Surge in Options ActivitySpotlight on Johnson & Johnson: Analyzing the Surge in Options Activity
benzinga.com - April 30 at 4:23 PM
Johnson & Johnson (NYSE:JNJ)  Shares Down 0.6% Johnson & Johnson (NYSE:JNJ) Shares Down 0.6%
marketbeat.com - April 30 at 3:37 PM
Stock Market Crash Warning: Dont Get Caught Holding These 3 Healthcare StocksStock Market Crash Warning: Don't Get Caught Holding These 3 Healthcare Stocks
investorplace.com - April 30 at 9:42 AM
3 Stocks Mega Investors Are Buying3 Stocks Mega Investors Are Buying
marketbeat.com - April 30 at 7:31 AM
3 Stocks Mega Investors Are Buying (JNJ)3 Stocks Mega Investors Are Buying (JNJ)
marketbeat.com - April 30 at 7:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

American Express logo

American Express

NYSE:AXP
American Express Company, together with its subsidiaries, operates as integrated payments company in the United States, Europe, the Middle East and Africa, the Asia Pacific, Australia, New Zealand, Latin America, Canada, the Caribbean, and Internationally. It operates through four segments: U.S. Consumer Services, Commercial Services, International Card Services, and Global Merchant and Network Services. The company's products and services include credit card, charge card, banking, and other payment and financing products; network services; expense management products and services; and travel and lifestyle services. It also provides merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. In addition, the company operates lounges at airports under Centurion Lounge brand name. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, affiliate marketing, customer referral programs, third-party service providers and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.